| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $88.2M | +31.2% |
| SG&A Expense | $30.4M | +32.4% |
| Operating Income | -$118.5M | -31.5% |
| Income Tax | $0 | — |
| Net Income | -$116.3M | -29.5% |
| EPS (Basic) | -$2.64 | -28.2% |
| EPS (Diluted) | -$2.64 | -28.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.3M | -74.8% |
| Short-term Investments | $172.2M | +66.6% |
| Current Assets | $230.8M | -10.8% |
| Total Assets | $278.8M | -24.0% |
| Current Liabilities | $17.2M | +38.6% |
| Total Liabilities | $20.4M | +64.3% |
| Stockholders' Equity | $223.5M | -30.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.0M | -25.3% |
| Capital Expenditures | $2.7M | +253.6% |
| Investing Cash Flow | -$6.8M | +96.2% |
| Financing Cash Flow | $1.2M | -96.8% |
| Free Cash Flow | -$91.8M | -27.7% |